New Delhi: Jubilant Pharmova Ltd on Friday said the US health regulator has completed an inspection of the contract manufacturing facility of its group firm Jubilant HollisterStier LLC located in Spokane, USA, with eight observations.
The US Food and Drug Administration (USFDA) has concluded an inspection of Jubilant HollisterStier LLC (JHS)'s contract manufacturing facility located in Spokane, Washington on June 17, 2026, Jubilant Pharmova said in a regulatory filing.